2024
Tailoring neo/adjuvant systemic therapy in breast cancer: “The advent of a personalized approach”—The Breast‐Gynecological and Immuno‐Oncology International Cancer Conference (BGICC) consensus and recommendations
Elghazaly H, Azim H, Rugo H, Cameron D, Swain S, Curigliano G, Harbeck N, Tripathy D, Arun B, Aapro M, Piccart M, Cardoso F, Gligorov J, Elghazawy H, Saghir N, Penault‐Llorca F, Perez E, Poortmans P, Abdelaziz H, El‐Zawahry H, Kassem L, Sabry M, Viale G, Al‐Sukhun S, Gado N, Leung J, Elarab L, Cardoso M, Karim K, Foheidi M, Elmaadawy M, Conte P, Selim A, Kandil A, Kamal R, Paltuev R, Guarneri V, Abulkhair O, Zakaria O, Golshan M, Orecchia R, ElMahdy M, Abdel‐Aziz A, Eldin N. Tailoring neo/adjuvant systemic therapy in breast cancer: “The advent of a personalized approach”—The Breast‐Gynecological and Immuno‐Oncology International Cancer Conference (BGICC) consensus and recommendations. Cancer 2024 PMID: 38985794, DOI: 10.1002/cncr.35389.Peer-Reviewed Original ResearchBreast cancerNeoadjuvant therapyManagement of early breast cancerEarly breast cancerIndividual patient managementDe-escalation strategiesModified Delphi approachBC expertsPostneoadjuvant treatmentSystemic therapyClinical evidencePatient managementConsensus recommendationsClinical situationsTherapyDe-escalationDelphi approachTherapy outcomeTreatment settingsCancerExpert opinionRecommendationsBreastConsensus
2018
25 Examination Techniques Roles of the Physician and Patient in Evaluating Breast Disease
Mallory M, Golshan M. 25 Examination Techniques Roles of the Physician and Patient in Evaluating Breast Disease. 2018, 331-336.e2. DOI: 10.1016/b978-0-323-35955-9.00025-8.Peer-Reviewed Original Research
2015
The survival benefit offered by the surgical management of low-grade ductal carcinoma in situ of the breast.
Sagara Y, Barry W, Mallory M, Wong S, Aydogan F, DeSantis S, Golshan M. The survival benefit offered by the surgical management of low-grade ductal carcinoma in situ of the breast. Journal Of Clinical Oncology 2015, 33: 1006-1006. DOI: 10.1200/jco.2015.33.15_suppl.1006.Peer-Reviewed Original Research
2014
Genetic Predisposition to Breast Cancer
Golshan M. Genetic Predisposition to Breast Cancer. 2014, 263-264. DOI: 10.1007/978-1-4939-1565-1_66.Peer-Reviewed Original ResearchBreast cancer casesBreast cancerCancer casesInvasive breast cancerCancer-related deathOvarian cancer accountsHereditary breast cancerCancer accountsCommon cancerLifetime riskMutation carriersGenetic predispositionBRCA2 genesCancerWomenAmerican womenPredispositionBRCA1Large proportionBreastDiseaseCases
2013
Management of the axilla II
Dominici L, Golshan M. Management of the axilla II. 2013, 441-446. DOI: 10.1201/b13937-44.Peer-Reviewed Original ResearchSystemic therapyBreast cancerTumor biologyIndividual patient's tumor biologyAdjuvant treatment recommendationsPatient's tumor biologyAxillary lymph nodesWhole breast irradiationPatients breast cancerNovel chemotherapeutic agentsEndocrine therapyLocal therapyLymph nodesTreatment recommendationsAromatase inhibitorsRadiation therapyLocal controlTherapyChemotherapeutic agentsAccelerated formsSame periodMethods of evaluationCancerBreast
2008
Breast Pain
Golshan M. Breast Pain. 2008, 345-346. DOI: 10.1007/978-0-387-75246-4_85.Peer-Reviewed Original ResearchBreast painFourth of womenOvarian estrogen productionBreast nodularityBreast symptomsHormonal milieuEstrogen productionCommon complaintPalpable abnormalityProgesterone secretionBreast cancerHormonal changesPainPatientsNodularityCommon typeMensesCancerBreastWomenHyperprolactinemiaCommon patternSymptomsMenstruationAbnormalities